Breast Cancer Clinical Trial

Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography

Summary

This was a multi-center, prospective clinical trial in which the subject was her own control. Approximately 950-1400 female subjects were enrolled at five (5) sites in the United States. Subjects were from either a Screening population or a biopsy population and were imaged first on a conventional 2D full filed digital mammography system then on a 3D tomosynthesis system.

The resulting images from the this portion of the study were then randomized into a reader study.

The purpose of this clinical study was to compare the 3-D tomosynthesis system used in conjunction with a conventional 2-D digital imaging system (2-D plus 3-D images) to the conventional 2-D digital imaging system (2-D images), and to determine whether the 2-D plus 3-D images compared to the 2-D images alone would:

Reduce the recall rate And/or
Improve ROC area due to improved breast cancer detection and/or improved lesion classification.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female
Any ethnic origin
No contraindication for screening mammography

Exclusion Criteria:

Significant breast trauma
Pregnancy
Lactating
Breast implants
Previous breast cancer
Previous surgical biopsy
Placement of an internal breast marker
Unable to understand and or execute written informed consent

Study is for people with:

Breast Cancer

Estimated Enrollment:

1183

Study ID:

NCT00754598

Recruitment Status:

Completed

Sponsor:

Hologic, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 5 Locations for this study

See Locations Near You

Yale New Haven Hospital
New Haven Connecticut, 06520, United States
University of Iowa Medical Center
Iowa City Iowa, 52242, United States
Massachusetts General Hospital
Boston Massachusetts, 02116, United States
Dartmouth Hitchcock Medical Center
Lebanon New Hampshire, 03756, United States
Magee Women's Hospital
Pittsburgh Pennsylvania, 15213, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

1183

Study ID:

NCT00754598

Recruitment Status:

Completed

Sponsor:


Hologic, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider